Sustainability of motor performance after robotic-assisted treadmill therapy in children: an open, non-randomized baseline-treatment study
Standard
Sustainability of motor performance after robotic-assisted treadmill therapy in children: an open, non-randomized baseline-treatment study. / Borggraefe, I; Kiwull, Lorenz; Schaefer, J S; Koerte, I; Blaschek, A; Meyer-Heim, A; Heinen, F.
in: EUR J PHYS REHAB MED, Jahrgang 46, Nr. 2, 06.2010, S. 125-31.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Sustainability of motor performance after robotic-assisted treadmill therapy in children: an open, non-randomized baseline-treatment study
AU - Borggraefe, I
AU - Kiwull, Lorenz
AU - Schaefer, J S
AU - Koerte, I
AU - Blaschek, A
AU - Meyer-Heim, A
AU - Heinen, F
PY - 2010/6
Y1 - 2010/6
N2 - AIM: The aim of the study was to investigate the sustainability of motor improvements achieved after a three week trial of robotic assisted treadmill therapy in children and adolescents with central gait disorders within a follow up period of about six months.METHODS: Open, non-randomized, baseline-treatment study. Fourteen patients (mean age 8.2+/-5.4) underwent a trial of 12 sessions of robotic-assisted treadmill therapy using the Lokomat over a period of three weeks. Outcome measures were the dimensions D (standing) and E (walking) of the Gross Motor Function Measure, the ten meter walking test and the six minute walking test. Outcome variables were evaluated immediately before and after the trial and at a follow up of about six months.RESULTS: Improvements after the trial in the dimension D from 49.5% to 54.4% (P=0.008) and from 38.9% to 42.3% (P=0.012) in the dimension E of the GMFM were seen and are within the same range of previously published results. The mean score at the follow up after six months was 56.8% and 43.3% for dimension D and E, respectively. Gait speed improved from 0.80 m/s to 1.01 m/s (P=0.006) after the trial and was 1.11 m/s at the follow-up visit at six months. Similar results were obtained for endurance.CONCLUSION: The improvements of motor function after a three-week trial of robotic-assisted treadmill therapy appear to be sustained after a mean period of six months.
AB - AIM: The aim of the study was to investigate the sustainability of motor improvements achieved after a three week trial of robotic assisted treadmill therapy in children and adolescents with central gait disorders within a follow up period of about six months.METHODS: Open, non-randomized, baseline-treatment study. Fourteen patients (mean age 8.2+/-5.4) underwent a trial of 12 sessions of robotic-assisted treadmill therapy using the Lokomat over a period of three weeks. Outcome measures were the dimensions D (standing) and E (walking) of the Gross Motor Function Measure, the ten meter walking test and the six minute walking test. Outcome variables were evaluated immediately before and after the trial and at a follow up of about six months.RESULTS: Improvements after the trial in the dimension D from 49.5% to 54.4% (P=0.008) and from 38.9% to 42.3% (P=0.012) in the dimension E of the GMFM were seen and are within the same range of previously published results. The mean score at the follow up after six months was 56.8% and 43.3% for dimension D and E, respectively. Gait speed improved from 0.80 m/s to 1.01 m/s (P=0.006) after the trial and was 1.11 m/s at the follow-up visit at six months. Similar results were obtained for endurance.CONCLUSION: The improvements of motor function after a three-week trial of robotic-assisted treadmill therapy appear to be sustained after a mean period of six months.
KW - Adolescent
KW - Adult
KW - Child
KW - Child, Preschool
KW - Exercise Therapy
KW - Female
KW - Gait Disorders, Neurologic
KW - Humans
KW - Male
KW - Robotics
KW - Treatment Outcome
KW - Walking
KW - Young Adult
KW - Clinical Trial
KW - Journal Article
M3 - SCORING: Journal article
C2 - 20485217
VL - 46
SP - 125
EP - 131
JO - EUR J PHYS REHAB MED
JF - EUR J PHYS REHAB MED
SN - 1973-9087
IS - 2
ER -